Focus on the more critical issues in healthcare

I UNDERSTAND that a cost benefit assessment (CBA) was carried out from Nov 29 to Dec 8 to get the stakeholders’ feedback on the government’s proposed new medicine pricing policy, which is expected to have a significant impact on the private healthcare sector.

Are we just focusing on a very small segment of the private healthcare delivery system? Who are going to benefit from this price control policy?

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 31
Cxense type: NA
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Letters

Vape is part of the nicotine problem
Curbing the use of tobacco Premium
Fingers crossed as Omicron wave strikes Premium
Serdang landslip: Find out root cause of issue before rebuilding to avoid future troubles
Order the corrupt to talk Premium
Insurance firms defining docs’ job scope Premium
Recovery of businesses hampered by labour shortage Premium
Achieving recycling target Premium
Teachers should stick to core duties Premium
Keep teachers out of politics Premium

Others Also Read